J&J Vaccine Helps, But Is Not a Game Changer: Johns Hopkins

3 Просмотры
-- Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses the vaccination race against virus variants, approval of the Johnson & Johnson vaccine, and falling hospitalization rates following the ramping up of vaccinations. He speaks on “Bloomberg Surveillance Early Edition.” The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.
Видео про игры
Комментариев нет.